Milestones in Antiplatelet Therapy
An article on antiplatelet therapy by Andrew I. Schafer, MD, and these accompanying milestones were published in December 2008 as part of the special ASH anniversary brochure, 50 Years in Hematology: Research That Revolutionized Patient Care.
| 1882 | Giulio Bizzozero describes blood platelets. |
| 1953 | Lawrence Craven reports that aspirin prevents heart attacks. |
| 1960s | Harvey Weiss, Sir John Vane, Philip Majerus, Gerald Roth, and others elucidate the antiplatelet actions of aspirin. |
| 1970s | Alan T. Nurden, Jacques P. Caen, David R. Phillips, and others describe the molecular basis of platelet aggregation. |
| 1994 | Barry Coller's monoclonal antibody to platelet GP IIb/IIIa is approved for use in coronary angioplasty. |
| 1998 | ADP receptor antagonists are shown to be effective antiplatelet agents in preventing coronary stent thrombosis. |
Help ASH Build an Inclusive Hematology Community!
ASH is committed to building and nurturing a global hematology community and workforce inclusive of diverse perspectives, talents, and experiences as it works toward one collective goal: helping hematologists conquer blood diseases worldwide.
How Can You Help?
Visit your My Account page, make needed updates to your demographic details, and select your preferred level of ASH access to your information; aggregated or individually identifiable, or choose not to provide or share your information. By sharing information about who you are, you will help ASH have a better appreciation of the diverse needs and talents present in the field, and help to build a more inclusive, collaborative hematology community. It will take only a few moments to complete!
Update Access to Demographic Information Learn About Our Mission